ResMed Inc.
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionLazard Asset Management Llc
Latest Disclosed Ownership3,272 shares
Latest Disclosed Value $ 734,499
Lazard Asset Management Llc reports 67.98% decrease in ownership of RMD / ResMed Inc.

On May 15, 2026 - Lazard Asset Management Llc filed a 13F-HR form disclosing ownership of 3,272 shares of ResMed Inc. (MX:RMD) valued at $734,499 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 10,220 shares of ResMed Inc.. This represents a change in shares of -67.98% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F RESMED COM 761152107 3,272 -6,948 -67.98 734 -70.17 0.0006
2026-02-17 2025-12-31 13F RESMED COM 761152107 10,220 1,548 17.85 2,462 3.71 0.0042
2025-11-14 2025-09-30 13F RESMED COM 761152107 8,672 -3,011 -25.77 2,374 79,000.00 0.0032
2025-08-14 2025-06-30 13F RESMED Common Stock 761152107 11,683 360 3.18 3 50.00 0.0041
2025-05-15 2025-03-31 13F RESMED Common Stock 761152107 11,323 2,061 22.25 3 0.00 0.0039
2025-02-14 2024-12-31 13F RESMED Common Stock 761152107 9,262 -1,080 -10.44 2 0.00 0.0031
2024-11-14 2024-09-30 13F RESMED Common Stock 761152107 10,342 -897 -7.98 3 0.00 0.0034
2024-08-14 2024-06-30 13F RESMED Common Stock 761152107 11,239 11,187 21,513.46 2 0.0027
2024-07-09 2024-03-31 13F/A-1 RESMED Common Stock 761152107 52 0 0.00 0 0.0000
2024-05-14 2024-03-31 13F RESMED Common Stock 761152107 52 0 0 0.0000
2024-02-14 2023-12-31 13F RESMED Common Stock 761152107 52 1 1.96 0 0.0000
2023-11-14 2023-09-30 13F RESMED Common Stock 761152107 51 -5,085 -99.01 0 -100.00 0.0000
2023-08-15 2023-06-30 13F RESMED Common Stock 761152107 5,136 1,456 39.57 1 0.0014
2023-05-15 2023-03-31 13F RESMED Common Stock 761152107 3,680 -3 -0.08 1 -100.00 0.0011
2023-02-15 2022-12-31 13F RESMED Common Stock 761152107 3,683 -111 -2.93 766 -7.49 0.0011
2022-11-14 2022-09-30 13F RESMED Common Stock 761152107 3,794 40 1.07 828 5.34 0.0012
2022-08-09 2022-06-30 13F RESMED Common Stock 761152107 3,754 -34,566 -90.20 786 -91.54 0.0011
2022-05-13 2022-03-31 13F RESMED Common Stock 761152107 38,320 -4,345 -10.18 9,292 -16.39 0.0108
2022-02-09 2021-12-31 13F RESMED Common Stock 761152107 42,665 -671 -1.55 11,113 -2.69 0.0118
2021-11-15 2021-09-30 13F RESMED Common Stock 761152107 43,336 -6,932 -13.79 11,420 -7.84 0.0129
2021-08-12 2021-06-30 13F RESMED Common Stock 761152107 50,268 14,992 42.50 12,391 81.08 0.0139
2021-05-14 2021-03-31 13F RESMED Common Stock 761152107 35,276 23,355 195.91 6,843 170.15 0.0083
2021-02-11 2020-12-31 13F RESMED Common Stock 761152107 11,921 11,421 2,284.20 2,533 2,880.00 0.0032
2020-11-13 2020-09-30 13F RESMED Common Stock 761152107 500 -116 -18.83 85 -27.97 0.0001
2020-08-13 2020-06-30 13F RESMED Common Stock 761152107 616 5 0.82 118 32.58 0.0002
2020-05-14 2020-03-31 13F RESMED Common Stock 761152107 611 -394 -39.20 89 -42.58 0.0002
2020-02-13 2019-12-31 13F RESMED Common Stock 761152107 1,005 505 101.00 155 131.34 0.0002
2019-11-14 2019-09-30 13F RESMED Common Stock 761152107 500 -13,037 -96.31 67 -95.94 0.0001
2019-08-14 2019-06-30 13F RESMED Common Stock 761152107 13,537 112 0.83 1,651 18.35 0.0027
2019-08-28 2019-03-31 13F/A-1 RESMED Common Stock 761152107 13,425 13,425 60,922.73 1,395 139,400.00 0.0023
2019-05-13 2019-03-31 13F RESMED Common Stock 761152107 13,425 13,425 1,395
2016-08-15 2016-06-30 13F RESMED Common Stock 761152107 0 -22 -100.00 0 -100.00
2019-07-25 2016-03-31 13F/A-1 RESMED Common Stock 761152107 22 0 0.00 1 0.00 0.0000
2019-07-24 2015-12-31 13F/A-1 RESMED Common Stock 761152107 22 22 1 0.0000
2016-02-12 2015-12-31 13F RESMED Common Stock 761152107 22 22 1
2019-08-29 2014-12-31 13F/A-3 RESMED Common Stock 761152107 0 -47 -100.00 0 -100.00
2014-11-07 2014-09-30 13F RESMED Common Stock 761152107 47 -2,460 -98.13 2 -98.21 0.0000
2014-05-12 2014-03-31 13F RESMED Common Stock 761152107 2,507 -43,074 -94.50 112 -94.78 0.0003
2014-02-14 2013-12-31 13F RESMED Common Stock 761152107 45,581 17,043 59.72 2,145 42.43 0.0048
2014-01-13 2013-09-30 13F/A-1 RESMED Common Stock 761152107 28,538 28,538 1,506 0.0036
2013-11-13 2013-09-30 13F RESMED Common Stock 761152107 28,538 1,506 0.0032
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.